Read by QxMD icon Read


Iulia Ioana Roman, Teodora Mocan, Meda-Sandra Orasan, Elena Mihaela Jianu, Carmen-Angela Sfrangeu, Remus-Ioan Orasan
Background and aim: Psoriasis vulgaris, a chronic inflammatory skin disease, requires a long term medication, in order to avoid relapsing episodes. TNF-alpha, one of the targeted molecule in psoriasis therapy, seems to be also involved in thyroid disorders etiopathogenesis. The aim of this study was to evaluate the relationship between anti TNF-alpha therapy and thyroid parameters: serum level of triiodothyronine (T3), free thyroxine (FT4), thyroid-stimulating hormone (TSH) and antithyroidperoxidase antibody (AbTPO) in psoriasis treated population...
2018: Clujul Medical (1957)
Julia Rocha Silva Santos, Dâmia Leal Vendramini, José Augusto da Costa Nery, João Carlos Regazzi Avelleira
One of the biggest challenges in treating leprosy is the control of reaction events. Patients with lepromatous leprosy may present reaction type II, or erythema nodosum leprosum, during treatment, and this reaction can remain in a recurrent form after being released from the hospital, requiring the use of thalidomide and/or prednisone for long periods of time, in turn increasing the risk of side effects. Two reports of the use of antiTNF to treat erythema nodosum leprosum were found in the literature. A good response was found after an assay with infliximab and etanercept...
July 2017: Anais Brasileiros de Dermatologia
Belén Agudo, Gema Díaz, Yago González-Lama
No abstract text is available yet for this article.
December 2016: Journal of Crohn's & Colitis
Kristen K Lee, Bindia Jharap, Elena A Maser, Jean-Frederic Colombel
BACKGROUND: Inflammatory bowel disease (IBD) and endometriosis are immune-mediated chronic inflammatory disorders affecting young women. The clinical significance of concomitant endometriosis on the course of IBD has not been previously studied. The aim of this study was to determine whether women with concomitant endometriosis and IBD have a unique phenotype and worse prognosis of IBD. METHODS: This was a case-control study performed at a tertiary referral center...
January 2016: Inflammatory Bowel Diseases
Alexandru Lupu, Mircea Diculescu, Razvan Diaconescu, Marcel Tantau, Alina Tantau, Ioana Visovan, Cristian Gheorghe, Cristina Lupei, Liana Gheorghe, Razvan Cerban, Roxana Vadan, Adrian Goldis
BACKGROUND AND AIMS: Anemia is the most frequent systemic complication in inflammatory bowel diseases. It affects the quality of life and can interact with working capacity. Our objectives were to identify the prevalence of anemia, its main causes and its management in patients with inflammatory bowel disease from Romania. METHODS: We conducted a multicenter prospective study from March 2013 to August 2014. We enrolled 291 patients from three referral centers: 115 (39...
March 2015: Journal of Gastrointestinal and Liver Diseases: JGLD
(no author information available yet)
No abstract text is available yet for this article.
February 2015: Journal of Crohn's & Colitis
(no author information available yet)
No abstract text is available yet for this article.
February 2015: Journal of Crohn's & Colitis
(no author information available yet)
No abstract text is available yet for this article.
February 2015: Journal of Crohn's & Colitis
Sophie Ribière, Yoram Bouhnik
The evolution of inflammatory bowel disease (IBD) is characterized by the occurrence of gastrointestinal complications. For Crohn's disease (CD), it is mainly strictures, fistulas and abdominal or pelvic abscess in luminal forms and perianal lesions (ulcers, fissures, fistula/abscess) in the perineal forms. For ulcerative colitis (UC), main complications are severe flare up and dysplasia/cancer. In Crohn's disease, stenosis can be treated medically in first line (steroid-immunosupppresseurs or antiTNF) especially when the inflammatory component is predominant or in extensive lesions...
November 2014: La Revue du Praticien
Claudia Herrera-deGuise, Francesc Casellas, Virginia Robles, Ester Navarro, Natalia Borruel
BACKGROUND AND AIM: Crohn's disease (CD) impairs patients' health-related quality of life (HRQoL), therefore a goal of treatment is to improve their health. Recently, a more ambitious therapeutic target has been proposed, to reestablish patients' HRQoL to normal standards. There is no information on long-term prognostic value of restoring the health of patients with CD. Our aim was to determine if early restoration of HRQoL with antitumor necrosis factor (anti-TNF) agents is associated with long-term clinical remission...
February 2015: Journal of Gastroenterology and Hepatology
C Parker, M Gunn
INTRODUCTION: A European consensus on issues surrounding IBD in pregnancy was published in 2010(.1) We conducted a questionnaire to gain information about knowledge and management of IBD in pregnancy in the Northern region in both gastroenterology consultants and specialist trainees. METHODS: A questionnaire assessing the management of IBD in pregnancy and pre-conception was devised. 34 questionnaires were given out at a joint trainee and trainer teaching session and were completed anonymously...
June 2014: Gut
Alex Cañas-Ventura, Lucia Márquez, Elena Ricart, Eugeni Domènech, Javier P Gisbert, Valle García-Sanchez, Ignacio Marín-Jiménez, Francisco Rodriguez-Moranta, Fernando Gomollón, Xavier Calvet, Olga Merino, Esther Garcia-Planella, Narcis Vázquez-Romero, Maria Esteve, Marisa Iborra, Ana Gutiérrez, Maribel Vera, Montserrat Andreu
BACKGROUND AND AIMS: Little is known about the risk factors of colectomy in patients with ulcerative colitis (UC) under thiopurine treatment. The aim of the study was to determine the prevalence and the predictive risk factors of colectomy in an extensive cohort of patients with UC treated with thiopurines in Spain. METHODS: Among 5753 UC patients, we identified those diagnosed between 1980 and 2009 and treated with azathioprine or mercaptopurine (AZA/MP). We analyzed the age at diagnosis, familial history of IBD, extraintestinal manifestations (EIMs), disease extent, smoking status and treatment requirements (AZA/MP, cyclosporine (CsA) or anti-TNFα)...
October 2014: Journal of Crohn's & Colitis
Gabriela Romero, Olaia Ochoteco, David J Sanz, Irina Estrela-Lopis, Edwin Donath, Sergio E Moya
A strategy of encapsulation of the antiTNF-α antibody on top of poly(lactide-co-glycolide) nanoparticles (PLGA NPs) is presented on the basis of the complexation of antiTNF-α with alginate (Alg) and subsequent assembly layer by layer with poly(L-lysine) (PLL). The assembly of the antiTNF-α/Alg complex with PLL and its stability in PBS and lysozymes are monitored on a planar support using a quartz crystal microbalance with dissipation. The assembly of the antiTNF-α/Alg complex on PLGA NPs is followed by zeta potential measurements...
July 2013: Macromolecular Bioscience
Maria del Carmen Castro Villegas, Alejandro Escudero Contreras, Maria Dolores Miranda García, Eduardo Collantes Estévez
TNFalpha inhibitors have been a major advance in the treatment of spondyloarthropathies, having demonstrated their safety and efficacy, with higher response and survival rates than those observed in patients with rheumatoid arthritis. The fact that disease modifying anti-arthritic drugs (DMARD) have shown utility in the treatment of this disease, especially in the axial forms, gives them greater importance, since it is known that up to 30%of patients do not respond to treatment with non-steroidal anti-inflammatory drugs...
March 2012: Reumatología Clinica
Francesc Casellas, Virginia Robles, Natalia Borruel, Antonio Torrejón, Isabel Castells, Esther Navarro, Francisco Guarner
BACKGROUND: Inflammatory bowel disease impairs patients' health related quality of life (HRQOL). AntiTNFα agents control disease activity effectively. An ambitious goal of treatment is to achieve the normalization of health. This can be assessed by using a cut-off scoring threshold of the IBDQ-36 questionnaire. It has not been established if antiTNFα treatment is able to restore to normal patients' HRQOL. AIMS: To determine whether patients with Crohn's disease (CD) and ulcerative colitis (UC) in clinical remission after one year treatment with antiTNFα agents achieve normalization of their HRQOL...
October 2012: Journal of Crohn's & Colitis
Charalampos Lydakis, Despina Ioannidou, Irini Koumpa, Elpida Giannikaki, Evaggelos Thalassinos, Eleni Krasoudaki, Spiros Miyakis
We present a case of a patient treated with etanercept (TNF-a antagonist) for psoriatic arthritis, who then developed clinical symptoms of lepromatous leprosy. She presented with multiple erythematous plaques on trunk, face and extremities, saddle nose deformity, alopecia, articular deformities of the feet and peroneal neuropathy. The clinical suspicion of Hansen's Disase was confirmed by the biopsy findings (lepromatous leprosy). On further questioning, the patient stated that her father was diagnosed with leprosy 70 years ago and had spent some years in a leper colony in Spinalonga island in Southern Greece in the 1940s...
February 2012: Clinical Rheumatology
Srdan Novak
Disease activity assessment is a cornerstone of monitoring rheumatoid arthritis (RA) development and guidance for rituximab treatment. Beside clinical signs and symptoms biomarkers (RF and anti-CCP) are important early predictors of response to therapy and they can predict disease development. Autoantibody (RF and anti-CCP) seropositivity has been associated with positive response to rituximab (RTX) in antiTNF-IR patients, DMARD-IR patients and MTX-naive patients. Selecting therapy for TNF-IR patients providing most likely response it should be taken in consideration results form recently published assessments demonstrating for RTX treated patients significant improvement in DAS28 from baseline versus alternative TNF inhibitor treatment...
2010: Reumatizam
Antonino Spinelli, Gianluca M Sampietro, Piero Bazzi, Matteo Sacchi, Marco Montorsi
Ulcerative colitis (UC) is a chronic inflammatory condition of the mucosa affecting the rectum and extending up the colon in a continuous manner. Its etiology is unknown, but is most probably the result of the interaction of genetic and environmental factors. Approximately 30% of UC patients will need to undergo surgery at some point during their lifetime, despite progresses made in medical therapies. Indications for surgery include acute severe colitis with its complications, steroid-or antiTNF-refractory colitis (or growth impairment in children), and the onset of colorectal dysplasia/cancer...
September 2011: Current Drug Targets
Fernando Gomollón, Santiago García López
Crohn's disease (CD) is often very difficult to treat. Almost ten years ago "biologic" agents were introduced in the armamentarium to control CD. Although there are many new drugs in the pipeline, only two antiTNF agents have been released to the market (infliximab and, recently, adalimumab) and probably in 2008 certolizumab will be approved. A review of available evidence suggests that the three antibodies are effective in the induction and maintenance of response, and (to a lesser extent) remission. Infliximab has been very useful in fistulizing disease, and preliminary data do suggest that adalimumab and certolizumab will be also...
June 2008: Acta Gastroenterologica Latinoamericana
Hilario Nunes, Diane Bouvry, Paul Soler, Dominique Valeyre
Sarcoidosis is a multisystemic disorder of unknown cause characterized by the formation of immune granulomas in involved organs. It is an ubiquitous disease with incidence (varying according to age, sex, race and geographic origin) estimated at around 16.5/100,000 in men and 19/100,000 in women. The lung and the lymphatic system are predominantly affected but virtually every organ may be involved. Other severe manifestations result from cardiac, neurological, ocular, kidney or laryngeal localizations. In most cases, sarcoidosis is revealed by persistent dry cough, eye or skin manifestations, peripheral lymph nodes, fatigue, weight loss, fever or night sweats, and erythema nodosum...
November 19, 2007: Orphanet Journal of Rare Diseases
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"